Market Overview:
The global kidney cancer diagnostics market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of kidney cancer, technological advancements in diagnostic methods, and rising awareness about early diagnosis and treatment options for kidney cancer. The global renal cell carcinoma (RCC) diagnostics market is segmented on the basis of type, application, and region. The IHC segment is expected to account for the largest share of the global RCC diagnostics market in 2018 owing to its high accuracy rate and growing demand for personalized medicine.
Product Definition:
Kidney cancer diagnostics is the study of tissues or cells from the kidney to determine if cancer is present. The importance of kidney cancer diagnostics is that it allows for early detection and treatment of the disease.
Immunohistochemistry:
It is an important tool in kidney cancer research as it helps identify tumor-associated molecular patterns (TAMPs). IHC has been extensively used to detect and stage renal tumors, which have led to its increasing adoption rate in kidney cancer diagnostics.
Urine Analysis:
Urine analysis is a procedure wherein the urine is analyzed to detect any abnormal chemical changes that may be occurring in it. Urine analysis can detect certain cancer-related chemicals, such as uric acid and creatinine. The normal range of these urinary parameters varies with each person; hence, if an individual has a higher level than the average range, then this could indicate that there is a problem with his/her kidneys or they might have cancer.
Application Insights:
The others segment includes cystatin C and protein biomarker tests. Cystatin C is a serum protein that can be measured in the blood of patients with chronic kidney disease (CKD). It is used as a marker for monitoring the progression of CKD. The test also indicates the need for dialysis or renal replacement therapy in patients with end-stage kidney disease (ESRD).
In 2017, hospitals accounted for the largest share in terms of application and are expected to maintain its dominance throughout the forecast period owing to factors such as increasing prevalence of chronic diseases requiring frequent hospital visits, rising geriatric population susceptible to developing various conditions including ESRD, growing investments by governments towards improving healthcare infrastructure across countries including India, China and Brazil etc.,and last but not least; an increase in research & development activities pertaining towards new diagnostic methods related towards ESRD management.
Regional Analysis:
North America dominated the global kidney cancer diagnostics market in 2017. This can be attributed to the presence of key players, increased research & development activities, and high healthcare expenditure in this region. Moreover, increasing prevalence of chronic diseases such as kidney cancer is also expected to boost demand for these tests over the forecast period. For instance, according to statistics published by American Cancer Society in 2018, around 1 million new cases were estimated to be diagnosed globally during 2016 with more than 600 thousand deaths due to it.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing bothto an increase in R&D investment and a risein consumer awareness about early diagnosis of cancers especially those affecting internal organs such as kidneys and bladderThe rising number of patients from developing countries undergoing various diagnostic procedures has also contributed significantly towards regional growth.
Growth Factors:
- Increasing incidence of kidney cancer
- Growing awareness about kidney cancer and its early detection methods
- Rising demand for better and more accurate diagnostic tests
- Technological advancements in the field of kidney cancer diagnostics
- Growing number of research studies on kidney cancer
Scope Of The Report
Report Attributes
Report Details
Report Title
Kidney Cancer Diagnostics Market Research Report
By Type
Immunohistochemistry, Urine Analysis, Blood Chemistry Test, Others
By Application
Hospitals, Specialty Clinics, Others
By Companies
Thermo Fisher Scientific, Abbott Laboratories, Illumina, Quest Diagnostics Incorporated, Roche Holding, Myriad Genetics, NeoGenomics Laboratories, NanoString Technologies, Sysmex Corporation, Rosetta Genomics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
194
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Kidney Cancer Diagnostics Market Report Segments:
The global Kidney Cancer Diagnostics market is segmented on the basis of:
Types
Immunohistochemistry, Urine Analysis, Blood Chemistry Test, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialty Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Abbott Laboratories
- Illumina
- Quest Diagnostics Incorporated
- Roche Holding
- Myriad Genetics
- NeoGenomics Laboratories
- NanoString Technologies
- Sysmex Corporation
- Rosetta Genomics
Highlights of The Kidney Cancer Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunohistochemistry
- Urine Analysis
- Blood Chemistry Test
- Others
- By Application:
- Hospitals
- Specialty Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Kidney Cancer Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Kidney cancer diagnostics is the process of detecting kidney cancer in its early stages. This allows for more effective treatment and a better chance for survival.
Some of the key players operating in the kidney cancer diagnostics market are Thermo Fisher Scientific, Abbott Laboratories, Illumina, Quest Diagnostics Incorporated, Roche Holding, Myriad Genetics, NeoGenomics Laboratories, NanoString Technologies, Sysmex Corporation, Rosetta Genomics.
The kidney cancer diagnostics market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Kidney Cancer Diagnostics Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Kidney Cancer Diagnostics Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Kidney Cancer Diagnostics Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Kidney Cancer Diagnostics Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Kidney Cancer Diagnostics Market Size & Forecast, 2018-2028 4.5.1 Kidney Cancer Diagnostics Market Size and Y-o-Y Growth 4.5.2 Kidney Cancer Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Kidney Cancer Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Kidney Cancer Diagnostics Market Size Forecast by Type
5.2.1 Immunohistochemistry
5.2.2 Urine Analysis
5.2.3 Blood Chemistry Test
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Kidney Cancer Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Kidney Cancer Diagnostics Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Specialty Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Kidney Cancer Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Kidney Cancer Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Kidney Cancer Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America Kidney Cancer Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Kidney Cancer Diagnostics Market Size Forecast by Type
9.6.1 Immunohistochemistry
9.6.2 Urine Analysis
9.6.3 Blood Chemistry Test
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Kidney Cancer Diagnostics Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Specialty Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Kidney Cancer Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe Kidney Cancer Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Kidney Cancer Diagnostics Market Size Forecast by Type
10.6.1 Immunohistochemistry
10.6.2 Urine Analysis
10.6.3 Blood Chemistry Test
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Kidney Cancer Diagnostics Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Specialty Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Kidney Cancer Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Kidney Cancer Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Kidney Cancer Diagnostics Market Size Forecast by Type
11.6.1 Immunohistochemistry
11.6.2 Urine Analysis
11.6.3 Blood Chemistry Test
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Kidney Cancer Diagnostics Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Specialty Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Kidney Cancer Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America Kidney Cancer Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Kidney Cancer Diagnostics Market Size Forecast by Type
12.6.1 Immunohistochemistry
12.6.2 Urine Analysis
12.6.3 Blood Chemistry Test
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Kidney Cancer Diagnostics Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Specialty Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Kidney Cancer Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Kidney Cancer Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Kidney Cancer Diagnostics Market Size Forecast by Type
13.6.1 Immunohistochemistry
13.6.2 Urine Analysis
13.6.3 Blood Chemistry Test
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Kidney Cancer Diagnostics Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Specialty Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Kidney Cancer Diagnostics Market: Competitive Dashboard
14.2 Global Kidney Cancer Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 Abbott Laboratories
14.3.3 Illumina
14.3.4 Quest Diagnostics Incorporated
14.3.5 Roche Holding
14.3.6 Myriad Genetics
14.3.7 NeoGenomics Laboratories
14.3.8 NanoString Technologies
14.3.9 Sysmex Corporation
14.3.10 Rosetta Genomics